Bellevue Life Sciences Acquisition Corp. (BLAC)

Bellevue Life Sciences Acquisition will go public soon, but the exact IPO date is still unknown.
Stock Price: $10.00
Confirmed IPO price
Chart not available yet
Data will show when the stock starts trading.
Market Cap78.90M
Revenue (ttm)n/a
Net Income (ttm)n/a
Shares Out7.89M
EPS (ttm)n/a
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Openn/a
Previous Closen/a
Day's Rangen/a
52-Week Rangen/a
Betan/a
Analystsn/a
Price Targetn/a
Earnings Daten/a

About BLAC

Bellevue Life Sciences Acquisition is a newly organized blank check company incorporated in Delaware and formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities. We intend to focus our search on companies in the healthcare industry, more specifically in the biotechnology sector. We are focused on companies developing the next generation of biologics which include therapeutic antibodies, engineered...

IndustryBlank Check / SPAC
Founded2020
CEOKuk Hyoun Hwang
CountryUnited States
Stock ExchangeNASDAQ
Ticker SymbolBLAC
Full Company Profile

News

Biotech SPAC Bellevue Life Sciences Acquisition files for a $60 million IPO

Bellevue Life Sciences Acquisition, a blank check company backed by Bellevue Capital Management targeting the biotech sector, filed on Friday with the SEC to raise up to $60 million in an initial public...

3 weeks ago - Renaissance Capital

Bellevue Life Sciences Acquisition IPO Registration Document (S-1)

Bellevue Life Sciences Acquisition has filed to go public with an IPO on the NASDAQ.

3 weeks ago - SEC